MIRA Pharmaceuticals, Inc. (MIRA) Financials

$1.15

$0.05 (-4.17%)
Last update: 04:00 PM EST
Day's range
$1.13
Day's range
$1.28
$0$0-$2M-$2M-$4M-$4M-$6M-$6M-$8M-$8M-$10M-$10M-$12M-$12MEarning20202020202120212022202220232023202420246%6%5%5%4%4%3%3%2%2%1%1%0%0%Profit Margin
Profit Margin
Revenue
Earnings

MIRA Income statement / Annual

Last year (2024), MIRA Pharmaceuticals, Inc.'s total revenue was $0.00, and the percentage change from the previous year is not available. In 2024, MIRA Pharmaceuticals, Inc.'s net income was -$7.85 M. See MIRA Pharmaceuticals, Inc.,s key income statements, including revenue, expenses, profit, and income.

Period FY-2024 FY-2023 FY-2022 FY-2021 FY-2020
Period Ended 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020
Operating Revenue $0.00 $0.00 $0.00 $0.00 $0.00
Cost of Revenue $0.00 $8.53 M $0.00 $0.00 $0.00
Gross Profit $0.00 -$8.53 M $0.00 $0.00 $0.00
Gross Profit Ratio 0 0 0 0 0
Research and Development Expenses $3.31 M $1.57 M $2.35 M $684.45 K $14.65 K
General & Administrative Expenses $4.71 M $6.50 M $2.99 M $770.12 K $158.95 K
Selling & Marketing Expenses $0.00 $453.55 K $0.00 $0.00 $52.82 K
Selling, General & Administrative Expenses $4.71 M $6.95 M $2.99 M $770.12 K $52.98 K
Other Expenses $0.00 $0.00 -$1.70 M -$697.60 K $0.00
Operating Expenses $8.02 M $8.53 M $7.05 M $2.15 M $67.63 K
Cost And Expenses $0.00 $8.53 M $7.05 M $2.15 M $67.63 K
Interest Income $0.00 $0.00 $0.00 $0.00 $0.00
Interest Expense $165.67 K $3.46 M $10.25 K $24.37 K $364.00
Depreciation & Amortization -$165.67 K $8.53 M $7.05 M $2.15 M $202.89 K
EBITDA -$7.85 M $0.00 -$7.05 M -$2.15 M $0.00
EBITDA Ratio 0 0 0 0 0
Operating Income Ratio 0 0 0 0 0
Total Other Income/Expenses Net $165.67 K -$3.46 M -$10.25 K -$24.37 K $134.89 K
Income Before Tax -$7.85 M -$11.98 M -$7.06 M -$2.18 M -$67.99 K
Income Before Tax Ratio 0 0 0 0 0
Income Tax Expense $0.00 $0.00 -$7.05 K -$2.15 K -$202.89
Net Income -$7.85 M -$11.98 M -$7.06 M -$2.18 M -$67.99 K
Net Income Ratio 0 0 0 0 0
EPS -0.51 -0.65 -0.48 -0.15 -0.0046
EPS Diluted -0.51 -0.65 -0.48 -0.15 -0.0046
Weighted Average Shares Out $15.44 M $18.57 M $14.75 M $14.75 M $14.75 M
Weighted Average Shares Out Diluted $15.44 M $18.57 M $14.75 M $14.75 M $14.75 M
Link